Literature DB >> 1752020

Alfentanil infusion for sedation in infants and small children during cardiac catheterization.

P Rautiainen1.   

Abstract

We have analyzed several sedation techniques for paediatric cardiac catheterization which offer stable conditions for a few hours investigation, and maintain spontaneous breathing. In the present study, after premedication with oral flunitrazepam 0.1 mg.kg-1, 14 children aged 1-17 mo were sedated with an individually titrated alfentanil infusion. Every patient was sedated to a level which produced no reaction to pain or any discomfort. The induction dose and the maintenance requirement of alfentanil were 24 +/- 8 micrograms.kg-1 and 32 +/- 8 micrograms.kg-1.hr-1 (mean +/- SD), respectively. These doses were less in cyanotic than in acyanotic patients: 21 +/- 6 vs 28 +/- 8 micrograms.kg-1 and 29 +/- 10 vs 34 +/- 3 micrograms.kg-1.hr-1, respectively (P less than 0.05). The mean plasma concentration of alfentanil during maintenance of sedation was 79 +/- 23 ng.ml-1. Ventilation of two children was assisted for a short time after an incremental bolus of alfentanil. It is concluded that an alfentanil infusion technique with close monitoring of breathing is a practical sedation method for paediatric cardiac catheterization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752020     DOI: 10.1007/BF03008615

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  10 in total

1.  Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery.

Authors:  M E Ausems; C C Hug; D R Stanski; A G Burm
Journal:  Anesthesiology       Date:  1986-10       Impact factor: 7.892

2.  A comparison of alfentanil pharmacokinetics in children and adults.

Authors:  C Meistelman; C Saint-Maurice; M Lepaul; J C Levron; J P Loose; K Mac Gee
Journal:  Anesthesiology       Date:  1987-01       Impact factor: 7.892

3.  A simplified method of evaluating dose-effect experiments.

Authors:  J T LITCHFIELD; F WILCOXON
Journal:  J Pharmacol Exp Ther       Date:  1949-06       Impact factor: 4.030

4.  Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynamics and postoperative course.

Authors:  M Hynynen; O Takkunen; M Salmenperä; H Haataja; J Heinonen
Journal:  Br J Anaesth       Date:  1986-11       Impact factor: 9.166

5.  Alfentanil and fentanyl sedation in infants and small children during cardiac catheterization.

Authors:  O A Meretoja; P Rautiainen
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

6.  Alfentanil--a kinetically predictable narcotic analgesic.

Authors:  D R Stanski; C C Hug
Journal:  Anesthesiology       Date:  1982-12       Impact factor: 7.892

7.  The pharmacokinetics of alfentanil in children.

Authors:  G V Goresky; G Koren; M A Sabourin; J P Sale; L Strunin
Journal:  Anesthesiology       Date:  1987-11       Impact factor: 7.892

8.  Pharmacokinetics of alfentanil in newborn premature infants and older children.

Authors:  P J Davis; A Killian; R L Stiller; D R Cook; R D Guthrie; A M Scierka
Journal:  Dev Pharmacol Ther       Date:  1989

9.  Pharmacokinetics of alfentanil in children undergoing surgery.

Authors:  P Roure; N Jean; A C Leclerc; N Cabanel; J C Levron; P Duvaldestin
Journal:  Br J Anaesth       Date:  1987-11       Impact factor: 9.166

10.  Alfentanil in infants and children with congenital heart defects.

Authors:  J M den Hollander; P J Hennis; A G Burm; J G Bovill
Journal:  J Cardiothorac Anesth       Date:  1988-02
  10 in total
  2 in total

Review 1.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

2.  Alfentanil sedation for cardiac catheterization of children with Fontan shunts.

Authors:  P Rautiainen
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.